Anti-leishmanial drug discovery: rising to the challenges of a highly neglected disease.
Sharlow
Elizabeth R
ER
Drug Discovery Institute, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Grögl
Max
M
Johnson
Jacob
J
Lazo
John S
JS
D000818:Animals; D000981:Antiprotozoal Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D055808:Drug Discovery / Q000639:trends*; D005260:Female; D006801:Humans; D007891:Leishmania / Q000187:drug effects*; D007896:Leishmaniasis / Q000188:drug therapy* / Q000453:epidemiology* / Q000473:pathology
D000981:Antiprotozoal Agents